MedPath

Effects of turmeric on Helicobacter pylori infectio

Phase 3
Recruiting
Conditions
Helicobacter pylori.
Disease of stomach and duodenum, unspecified
K31.9
Registration Number
IRCT20190415043279N1
Lead Sponsor
Sanandaj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with dyspepsia, nausea, vomiting and epigastric inflammation, and evidence of Helicobacter infection after endoscopy, in which positive urease test and then Hpylori IgG test were positive.

Exclusion Criteria

HIV infection, known cancers, antibiotic use in a recent month, acute gastrointestinal bleeding, proton pump inhibitor intake in a recent month, pregnancy or breastfeeding, allergy to turmeric and gingerbread

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Helicobacter pylori eradication. Timepoint: 1 week after the end of medication. Method of measurement: UBT Test.
Secondary Outcome Measures
NameTimeMethod
Side effects of the treatment regimen. Timepoint: 1 week after the end of medication. Method of measurement: Asking the patient.
© Copyright 2025. All Rights Reserved by MedPath